- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo to glycopyrronium bromide
Total 1423 results
-
Novartis PharmaceuticalsRecruitingAsthmaSpain, Hungary, United Kingdom, South Africa, Colombia, Bulgaria, Poland, Guatemala
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingChronic Obstructive Pulmonary DiseaseChina
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Argentina, Germany, Russian Federation, France, Israel, Korea, Republic of, Italy, Poland, Chile, Mexico, Peru, Canada, Hungary, Netherlands, New Zealand
-
Novartis PharmaceuticalsCompletedCOPDGermany, Belgium, Poland, Romania, Italy, Spain, Estonia, Russian Federation, Austria, France, Slovakia, Czechia, Latvia, Lithuania, Greece, Hungary, United Kingdom, Portugal, Ireland, Norway, Slovenia, Denmark, Sweden
-
Daewoong Pharmaceutical Co. LTD.Completed
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedA Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)Andorra, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
AstraZenecaMenarini GroupCompletedPulmonary Disease, Chronic ObstructiveItaly, Spain, United Kingdom, Germany, Hungary
-
AstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Novartis PharmaceuticalsCompletedCOPDGermany, Spain, United Kingdom, Italy
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Greece, Belgium, Bulgaria, Turkey, Hungary, Slovakia, Spain, United Kingdom, Russian Federation, Ireland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina, Korea, Republic of
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
University of SaskatchewanCompleted
-
NPO PetrovaxActive, not recruitingInfections, CoronavirusRussian Federation, Slovakia
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, Belgium, Latvia, Lithuania, Japan
-
Prosonix LimitedCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Samsung Medical CenterRecruitingChronic Obstructive Pulmonary Disease | Non Small Cell Lung CancerKorea, Republic of
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | AsthmaUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Ukraine, Estonia, Belgium, France, Sweden, Netherlands, Philippines, Denmark, Hungary, Norway, Slovakia
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Spain, Turkey, France, Netherlands, Germany
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseRussian Federation, Singapore, United States, Canada, Korea, Republic of, Japan, Spain, Turkey, Romania, Australia, Netherlands
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Dr. August Wolff GmbH & Co. KG ArzneimittelCompletedPrimary Axillary HyperhidrosisGermany
-
Mersey Care NHS TrustUniversity of Central Lancashire; University of Manchester; Lancashire Care NHS... and other collaboratorsCompleted
-
Novartis PharmaceuticalsCompleted
-
Pearl Therapeutics, Inc.Completed
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease | COPDGermany
-
University of MilanFondazione Salvatore MaugeriCompletedChronic Obstructive Pulmonary DiseaseItaly
-
Sunovion Respiratory Development Inc.Completed
-
Boehringer IngelheimCompleted
-
McMaster UniversityBoehringer IngelheimCompleted
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Germany, Latvia, Lithuania, Slovenia
-
Wahba bakhetElite medical centerCompleted
-
Rajesh DesharCompletedHemodynamic Instability | Effect of Drug | Post-spinal Hypotension | GlycopyrrolateNepal
-
Boehringer IngelheimPfizerCompleted
-
Orion Corporation, Orion PharmaCompletedHealthy VolunteersFinland
-
Eurofarma Laboratorios S.A.Not yet recruitingChronic Obstructive Pulmonary DiseaseBrazil
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, Netherlands, Sweden
-
Boehringer IngelheimCompletedCystic FibrosisUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, New Zealand, Portugal, Russian Federation, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Russian Federation, Taiwan, Canada, Germany, Philippines, South Africa, Spain, United Kingdom, Turkey, Hungary, Guatemala, Australia, Bulgaria, France, Poland, Switzerland, Slovakia, Japan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Stefan Holubar MD MS FACS, FASCRSNot yet recruitingPostoperative IleusUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseJapan